These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 6381019

  • 1. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA, Przuntek H, Majer M, Welzel D.
    Dtsch Med Wochenschr; 1984 Aug 24; 109(34):1279-83. PubMed ID: 6381019
    [Abstract] [Full Text] [Related]

  • 2. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
    Mondal BK, Mondal KN.
    Pharmatherapeutica; 1986 Aug 24; 4(9):571-6. PubMed ID: 3094036
    [Abstract] [Full Text] [Related]

  • 3. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH, Oliver WA, Edwards RL.
    Clin Exp Neurol; 1990 Aug 24; 27():79-82. PubMed ID: 2129961
    [Abstract] [Full Text] [Related]

  • 4. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Vogel HP, Schiffter R.
    Pharmacopsychiatria; 1983 Jul 24; 16(4):107-10. PubMed ID: 6685318
    [Abstract] [Full Text] [Related]

  • 5. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S, Tolosa E, Burguera JA, Chacón J, Liaño H, Forcadell F.
    Clin Neuropharmacol; 1997 Feb 24; 20(1):67-76. PubMed ID: 9037575
    [Abstract] [Full Text] [Related]

  • 6. [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years].
    Montastruc JL, Rascol O, Rascol A.
    Therapie; 1988 Feb 24; 43(6):461-3. PubMed ID: 3227512
    [No Abstract] [Full Text] [Related]

  • 7. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA, Weiner WJ.
    Mov Disord; 1993 Jul 24; 8(3):257-62. PubMed ID: 8341289
    [Abstract] [Full Text] [Related]

  • 8. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A, Delwaide P, Jost W, Merello M, Williams A, Lamberti P, Aguilar M, Del Signore S, Cesaro P, Parkinson-Control Study Group.
    Mov Disord; 2006 Apr 24; 21(4):500-9. PubMed ID: 16267842
    [Abstract] [Full Text] [Related]

  • 9. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Gawel M, Riopelle R, Libman I, Bouchard S.
    Adv Neurol; 1987 Apr 24; 45():535-8. PubMed ID: 3548263
    [No Abstract] [Full Text] [Related]

  • 10. Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.
    Marion MH, Stocchi F, Quinn NP, Jenner P, Marsden CD.
    Adv Neurol; 1987 Apr 24; 45():493-6. PubMed ID: 3548262
    [No Abstract] [Full Text] [Related]

  • 11. Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.
    Przuntek H, Welzel D, Schwarzmann D, Letzel H, Kraus PH.
    Eur Neurol; 1992 Apr 24; 32 Suppl 1():36-45. PubMed ID: 1425819
    [Abstract] [Full Text] [Related]

  • 12. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan 24; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 13. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
    Nakanishi T, Mizuno Y, Goto I, Iwata M, Kanazawa I, Kowa H, Mannen T, Nishitani H, Ogawa N, Takahashi A.
    Eur Neurol; 1988 Jan 24; 28 Suppl 1():3-8. PubMed ID: 3378560
    [Abstract] [Full Text] [Related]

  • 14. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD, Delgado MR.
    Clin Neuropharmacol; 1985 Jan 24; 8(1):73-7. PubMed ID: 3978651
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN, Meerwaldt JD.
    Adv Neurol; 1987 Jan 24; 45():539-42. PubMed ID: 3103396
    [Abstract] [Full Text] [Related]

  • 16. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G, Casacchia M, Zamponi A, Agnoli A.
    Acta Neurol (Napoli); 1976 Jan 24; 31(4):479-48. PubMed ID: 1037427
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr 24; 14(76):51-4. PubMed ID: 15875340
    [Abstract] [Full Text] [Related]

  • 18. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
    Riopelle RJ, Gawel MJ, Libman I, King DB, McLean DR, Paulseth R, Raphy B, Bouchard S.
    Eur Neurol; 1988 Apr 24; 28 Suppl 1():11-4. PubMed ID: 3288477
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC, Mendoza MM, Yahr MD.
    Adv Biochem Psychopharmacol; 1980 Apr 24; 23():271-5. PubMed ID: 7395618
    [No Abstract] [Full Text] [Related]

  • 20. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL, Rascol O, Rascol A.
    Rev Neurol (Paris); 1990 Apr 24; 146(2):144-7. PubMed ID: 2181588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.